Methyldopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Methyldopa.
| Product ID | 51079-201_7cef7564-6b04-34a6-e053-2a91aa0ac2b0 |
| NDC | 51079-201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Methyldopa |
| Generic Name | Methyldopa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1998-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA070076 |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | METHYLDOPA |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1998-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA070076 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-09-01 |
| Marketing End Date | 2020-02-29 |
| Marketing Category | ANDA |
| Application Number | ANDA070076 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-09-01 |
| Marketing End Date | 2020-02-29 |
| Ingredient | Strength |
|---|---|
| METHYLDOPA | 500 mg/1 |
| SPL SET ID: | 227291e5-9baa-476a-93b8-b2142e61a4fe |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0421 | Methyldopa | methyldopa |
| 0378-0611 | Methyldopa | methyldopa |
| 16729-030 | Methyldopa | Methyldopa |
| 16729-031 | Methyldopa | Methyldopa |
| 21695-879 | Methyldopa | Methyldopa |
| 21695-880 | Methyldopa | Methyldopa |
| 42254-351 | Methyldopa | Methyldopa |
| 51079-200 | Methyldopa | methyldopa |
| 51079-201 | Methyldopa | methyldopa |
| 62135-321 | Methyldopa | Methyldopa |
| 62135-322 | Methyldopa | Methyldopa |
| 68151-2791 | Methyldopa | Methyldopa |